Ivan Ozerov
Jul 19, 2018 · 2 min read

My beloved company Insilico Medicine, Inc. today announced a research collaboration with computationally-driven biopharmaceutical company A2A Pharmaceuticals to develop novel small molecules for Duchenne Muscular Dystrophy (DMD) and other rare orphan diseases.

Duchenne is a fatal muscle disease that is caused by a mutation of the dystrophin gene. Since the disorder is X-linked recessive it affects approximately one in 3500 boys and 1 in 50 million girls. Starting with a muscle loss at 4 years old it worsens quickly and ends up with inability to walk at 12. And there is no cure yet.

I believe that there is no mission better than solving a problem with such a large deteriorating social and economical impact. And there is no better problem to apply advanced AI Technology that Insilico team has developed in recent years. For many years I was dreaming about highly impactful project able to change the life of the disabled children. Here it comes at Insilico. Support from a talented team of extremely experienced experts from A2A Pharma makes us even more confident in the indispensable success of the project. Please read more here.

Oh, and one more thing… a very similar strategy may be utilized to combat muscle wasting during Aging. And very recently we have published a paper how machine learning methods can be applied to search targets in muscle wasting.

InsilicoMedicine

Insilico Medicine is an artificial intelligence company focusing on drug discovery, biomarker development, digital medicine and aging research. It is developing a full-stack engine and naturally plug-and-play into the "Big Pharma", "Big Tech" and consumer companies.

Ivan Ozerov

Written by

InsilicoMedicine

Insilico Medicine is an artificial intelligence company focusing on drug discovery, biomarker development, digital medicine and aging research. It is developing a full-stack engine and naturally plug-and-play into the "Big Pharma", "Big Tech" and consumer companies.

Welcome to a place where words matter. On Medium, smart voices and original ideas take center stage - with no ads in sight. Watch
Follow all the topics you care about, and we’ll deliver the best stories for you to your homepage and inbox. Explore
Get unlimited access to the best stories on Medium — and support writers while you’re at it. Just $5/month. Upgrade